The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

A groundbreaking study suggests that Parkinson’s disease may begin in the kidneys, where a toxic protein builds up and ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

These indicators, known as ‘biomarkers’ – which include proteins, chemicals and other molecules that indicate normal or ...

New research reveals Parkinson’s disease may originate in the kidneys, where toxic protein buildup travels to the brain—offering fresh hope for early detection and treatment.

Diagnosing Parkinson's disease has always been a race against time. The later it’s found, the harder it is to treat.

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...